From Funder to Founder in Life Sciences AI

We sat down with Court Square Group for Season 2, Episode 12 of their series on life sciences investing and innovation, this time on the other side of the table: what it's like moving from funding life sciences AI companies to founding one.

What we covered

The conversation traces the path from sitting on the funder's side of the table, sourcing and evaluating life sciences AI companies, to starting Rightview and building for the friction we kept seeing in clinical trial execution firsthand. We talk through what that transition actually looks like: the shift in mindset from diligence to execution, what we learned from watching dozens of pitches before ever writing a plan of our own, and why the operational bottlenecks in trials (not the drug discovery headlines) are where we chose to build.

If you're evaluating life sciences AI as an investor, an operator, or a founder weighing the same jump, this one's worth a watch.